Articles with public access mandates - Cornelis HopLearn more
Not available anywhere: 2
Positron Emission Tomography Imaging of [11C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of …
S Billington, S Shoner, S Lee, K Clark‐Snustad, M Pennington, D Lewis, ...
Clinical Pharmacology & Therapeutics 106 (5), 1056-1066, 2019
Mandates: US National Institutes of Health
Interindividual variability in hepatic OATPs and P-glycoprotein (ABCB1) protein expression: quantification by LC-MS/MS and influence of genotype, age and sex
B Prasad, R Evers, A Gupta, CECA Hop, L Salphati, S Shukla, ...
Drug Metabolism and Disposition, 2013
Mandates: US National Institutes of Health
Available somewhere: 15
Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem …
B Prasad, R Evers, A Gupta, CECA Hop, L Salphati, S Shukla, ...
Drug Metabolism and Disposition 42 (1), 78-88, 2014
Mandates: US National Institutes of Health
Ontogeny of hepatic drug transporters as quantified by LC‐MS/MS proteomics
B Prasad, A Gaedigk, M Vrana, R Gaedigk, JS Leeder, L Salphati, X Chu, ...
Clinical Pharmacology & Therapeutics 100 (4), 362-370, 2016
Mandates: US National Institutes of Health
Transporter expression in liver tissue from subjects with alcoholic or hepatitis C cirrhosis quantified by targeted quantitative proteomics
L Wang, C Collins, EJ Kelly, X Chu, AS Ray, L Salphati, G Xiao, C Lee, ...
Drug Metabolism and Disposition 44 (11), 1752-1758, 2016
Mandates: US National Institutes of Health
Opportunities and challenges using artificial intelligence in ADME/Tox
B Bhhatarai, WP Walters, CECA Hop, G Lanza, S Ekins
Nature materials 18 (5), 418-422, 2019
Mandates: US National Institutes of Health
Drug concentration asymmetry in tissues and plasma for small molecule–related therapeutic modalities
D Zhang, CECA Hop, G Patilea-Vrana, G Gampa, HK Seneviratne, ...
Drug Metabolism and Disposition 47 (10), 1122-1135, 2019
Mandates: US National Institutes of Health
Toward a consensus on applying quantitative liquid chromatography‐tandem mass spectrometry proteomics in translational pharmacology research: a white paper
B Prasad, B Achour, P Artursson, CECA Hop, Y Lai, PC Smith, J Barber, ...
Clinical Pharmacology & Therapeutics 106 (3), 525-543, 2019
Mandates: US National Institutes of Health
Abundance of phase 1 and 2 drug-metabolizing enzymes in alcoholic and hepatitis C cirrhotic livers: a quantitative targeted proteomics study
B Prasad, DK Bhatt, K Johnson, R Chapa, X Chu, L Salphati, G Xiao, ...
Drug Metabolism and Disposition 46 (7), 943-952, 2018
Mandates: US National Institutes of Health
Interindividual and regional variability in drug transporter abundance at the human blood–brain barrier measured by quantitative targeted proteomics
S Billington, L Salphati, CECA Hop, X Chu, R Evers, D Burdette, ...
Clinical Pharmacology & Therapeutics 106 (1), 228-237, 2019
Mandates: US National Institutes of Health
A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834
JK Sodhi, S Wong, DS Kirkpatrick, L Liu, SC Khojasteh, CECA Hop, ...
Drug Metabolism and Disposition 43 (6), 908-915, 2015
Mandates: US National Institutes of Health
Transporter expression in noncancerous and cancerous liver tissue from donors with hepatocellular carcinoma and chronic hepatitis C infection quantified by LC-MS/MS proteomics
S Billington, AS Ray, L Salphati, G Xiao, X Chu, WG Humphreys, M Liao, ...
Drug Metabolism and Disposition 46 (2), 189-196, 2018
Mandates: US National Institutes of Health
An automated high-throughput metabolic stability assay using an integrated high-resolution accurate mass method and automated data analysis software
P Shah, E Kerns, DT Nguyen, RS Obach, AQ Wang, A Zakharov, J McKew, ...
Drug metabolism and disposition 44 (10), 1653-1661, 2016
Mandates: US National Institutes of Health
Intratumoral payload concentration correlates with the activity of antibody–drug conjugates
D Zhang, SF Yu, SC Khojasteh, Y Ma, TH Pillow, JD Sadowsky, D Su, ...
Molecular cancer therapeutics 17 (3), 677-685, 2018
Mandates: US National Institutes of Health
Development of robust quantitative structure-activity relationship models for CYP2C9, CYP2D6, and CYP3A4 catalysis and inhibition
E Gonzalez, S Jain, P Shah, N Torimoto-Katori, A Zakharov, ÐT Nguyễn, ...
Drug Metabolism and Disposition 49 (9), 822-832, 2021
Mandates: US National Institutes of Health
Intestinal excretion, intestinal recirculation, and renal tubule reabsorption are underappreciated mechanisms that drive the distribution and pharmacokinetic behavior of small …
D Zhang, C Wei, CECA Hop, MR Wright, M Hu, Y Lai, SC Khojasteh, ...
Journal of medicinal chemistry 64 (11), 7045-7059, 2021
Mandates: US National Institutes of Health
Towards a consensus on applying quantitative LC-MS/MS Proteomics in translational pharmacology research: a White Paper
B Prasad, B Achour, P Artursson, CECA Hop, Y Lai, PC Smith, J Barber, ...
Clinical pharmacology and therapeutics 106 (3), 525, 2019
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program